EUVIMEDEUVIMED entdecken
Crossref

Long‐term follow‐up of 35 dogs with meningoencephalitis of unknown origin treated with cytosine arabinoside and glucocorticosteroids

Jan Waelkens iD, Sofie F M Bhatti, Kimberley Stee iD, Ine Cornelis

Veterinary Record · 19.07.2025 · 197 (2)

DOI: 10.1002/vetr.5322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Record, online erschienen am 30.05.2025. Verfasst von Jan Waelkens und 3 weiteren Autor:innen. Beteiligte Einrichtung: Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium. Hauptthemen laut MEDLINE: Dog Diseases, Meningoencephalitis, Cytarabine, Glucocorticoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Meningoencephalitis of unknown origin (MUO) is an idiopathic immune‐mediated central nervous system disease. Glucocorticosteroids are the main treatment, often combined with cytosine arabinoside (CA).

Methods

This retrospective, descriptive study evaluated the outcome of a 69‐week protocol using glucocorticosteroids and CA (two initial constant rate infusions followed by recurrent subcutaneous injections) in dogs diagnosed with MUO. Outcomes (e.g., treatment success, relapse or death) at 25, 69 and 93 weeks were descriptively analysed and compared to similar protocols reported in the literature. Relapse timing was documented at different treatment stages and glucocorticosteroid dosages.

Results

Thirty‐five dogs met the inclusion criteria, of which six (17.1%) died within the first 7 days after diagnosis. Overall, 62.9% completed the 93‐week follow‐up, with 42.9% showing no relapse. Relapse occurred in 40% of dogs, with 20% of these relapsed dogs dying. The majority of dogs relapsed during the treatment protocol.

Limitations

Limitations include the study's retrospective and descriptive nature, small sample size and lack of histopathological confirmation.

Conclusion

The treatment protocol used in this study does not demonstrate superiority over protocols used in earlier studies. This study emphasises the need for long‐term follow‐up to detect relapses after treatment discontinuation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesMeningoencephalitisCytarabineGlucocorticoidsAnimalsDogsRetrospective StudiesFemaleMaleTreatment OutcomeFollow-Up StudiesDrug Therapy, CombinationRecurrence

Substanzen

CytarabineGlucocorticoids

Autor:innen und Institutionen

  • Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.

ORCID-Profile: Jan Waelkens, Kimberley Stee

Zitieren

APA

Waelkens, J., Bhatti, S. F. M., Stee, K., & Cornelis, I. (2025). Long‐term follow‐up of 35 dogs with meningoencephalitis of unknown origin treated with cytosine arabinoside and glucocorticosteroids. Veterinary Record, 197(2). https://doi.org/10.1002/vetr.5322

Vancouver

Waelkens J, Bhatti SFM, Stee K, Cornelis I. Long‐term follow‐up of 35 dogs with meningoencephalitis of unknown origin treated with cytosine arabinoside and glucocorticosteroids. Veterinary Record. 2025;197(2). doi:10.1002/vetr.5322

BibTeX
@article{Waelkens2025,
  author = {Waelkens, Jan and Bhatti, Sofie F M and Stee, Kimberley and Cornelis, Ine},
  title = {Long‐term follow‐up of 35 dogs with meningoencephalitis of unknown origin treated with cytosine arabinoside and glucocorticosteroids},
  journal = {Veterinary Record},
  year = {2025},
  volume = {197},
  number = {2},
  doi = {10.1002/vetr.5322}
}
Kostenlos starten →